Procter & Gamble Health Limited: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

Particulars	Mar-25	Jun-25	Sep-25	Dec-25	Mar-26
Revenue	311	339	325	374	370
Other income	3	4	5	4	4
Expenses	236	254	211	269	241
Cost of materials consumed	91	60	78	85	85
Purchases of stock-in-trade	14	24	11	13	22
Change in inventories	-6	10	-20	12	-15
Employee benefit expense	49	56	54	62	51
Finance costs	0.10	0.10	0.10	0.10	0.20
Depreciation & amortisation	5	5	6	6	6
Other expenses	83	98	82	92	91
EBITDA	84	94	125	115	139
EBIT	79	89	119	109	133
Profit Before Tax	79	89	119	109	133
Tax expense	17	23	31	31	39
Deferred tax	-3	-0.30	-0.10	-2	7
Net Profit	61	66	89	78	95
Financial Ratios
Operating Profit Margin	25.27%	26.22%	36.65%	29.17%	36.00%
EBITDA Margin	27.01%	27.82%	38.52%	30.75%	37.68%
Net Profit Margin	19.68%	19.53%	27.23%	20.75%	25.57%
Earnings Per Share (₹)	36.86	39.87	53.34	46.74	56.99

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.